Relative Value Partners Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Relative Value Partners Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$228K	Buy	+2,454	New	+$220K	0.03%	292
2022 Q1	–	Sell	-1,831	Closed	-$205K	–	259
2021 Q4	$205K	Hold	1,831	–	–	0.01%	178
2021 Q3	$230K	Hold	1,831	–	–	0.02%	176
2021 Q2	$248K	Hold	1,831	–	–	0.02%	169
2021 Q1	$248K	Sell	1,831 -418	-19%	-$62.6K	0.02%	184
2020 Q4	$317K	Sell	2,249 -40	-2%	-$5.12K	0.03%	164
2020 Q3	$255K	Hold	2,289	–	–	0.03%	157
2020 Q2	$256K	Buy	+2,289	New	+$225K	0.03%	152

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Relative Value Partners Group's XBI Position: Q2 2024 in Review

Relative Value Partners Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2024: 2,454 shares worth $228K. The stake represents 0.03% of the portfolio and ranks #292 among its holdings. This is a return to the name: Relative Value Partners Group previously reported a position in XBI as recently as Q4 2021.

Relative Value Partners Group first reported a position in XBI in Q2 2020 and has held it in 8 quarters since. The position peaked at $317K in Q4 2020. 762 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Relative Value Partners Group held 2,454 shares of State Street SPDR S&P Biotech ETF worth $228K as of Q2 2024.
State Street SPDR S&P Biotech ETF was a new Relative Value Partners Group position in Q2 2024.
State Street SPDR S&P Biotech ETF made up 0.03% of Relative Value Partners Group's portfolio in Q2 2024, its #292 holding.
Relative Value Partners Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 8 quarters since.
Relative Value Partners Group's State Street SPDR S&P Biotech ETF position peaked at $317K in Q4 2020.
762 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Relative Value Partners Group's 13F filing for Q2 2024, filed 12 Jul 2024.